2nd Novel Immunotherapeutics Summit
30 Jan 2013 - 01 Feb 2013 - San Diego, CA, USA
The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity, immunotoxicity, allergy and asthma will be discussed at the summit. The summit includes four concurrent tracks. In addition, an optional workshop will be held on Jan 30, 2013.
2nd Novel Immunotherapeutics Summit:
Workshop: Immune Responses in Tumor Microenvironment
Track: 5th Immunotherapeutics & Immunomonitoring
Track: 11th Cytokines & Inflammation
Track: 2nd Allergy Research & Drug Discovery
Track: Immunogenicity & Immunotoxicity
Network with representatives from prestigious organizations and discuss the latest research from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk, Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme, Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San Francisco, and many more!
Click here to register for the 2nd Novel Immunotherapeutics Summit.
Call for Papers!
To be considered for an oral presentation, please submit an abstract here by December 31, 2012. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
Sponsorship and exhibiting opportunities are available, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or email@example.com for more information.